NSCLC
544 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Inhaled Doxorubicin Plus IV Docetaxel and Cisplatin in Patients With Non-Small-Cell Lung Carcinoma (NSCLC) (NCT00082472) | Zivena | 2004-01-01 |
| Study of Outcomes of Radiofrequency Ablation of Lung Tumors (NCT00280189) | University of Pittsburgh | 2003-09-01 |
| Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study (NCT00242801) | AstraZeneca | 2003-07-01 |
| Phase II Study of Taxotere in Combination With Exisulind in Non-Small Cell Lung Cancer (NSCLC) Patients (NCT00072618) | Astellas Pharma Inc | 2001-10-01 |
| Personalized Neoantigen MRNA Vaccine Combined with Adebrelimab in Non-Small Cell Lung Cancer Patients (NCT06685653) | Nanjing Tianyinshan Hospital |
Track NSCLC automatically
Every clearance here is in the API, with alerts when new ones post.